PharmaDeals' new report on valuation provides an essential grounding in how to use proven and reliable methods for maximising the value of pharmaceutical and biotechnology projects.
- Provides a thorough understanding of robust valuation methodologies
- Enables more rigorous economic portfolio analysis
- Assists the formulation of attractive deal structures
- Offers greater transparency in portfolio analysis
- Permits accurate comparison of alternative deals
- Highlights the value creation process
- Minimises risk in future deals
Also available in Electronic version (ISBN: 978-0-9568270-5-0). Please contact us for a tailored quote for your organisation.